Revolution Medicines (RVMD) Accumulated Expenses (2019 - 2026)
Revolution Medicines' Accumulated Expenses came in at $248.89 million for Q2 2026, up 117.0% from $114.69 million a year earlier and up 29.3% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Revolution Medicines' Accumulated Expenses was $209.34 million, up 116.7% from FY2024.
- Accumulated Expenses has increased in each of the last six years, with a five-year compound annual growth rate of 62.0% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $96.62 million in FY2024 (+29.3%), $74.69 million in FY2023 (+153.7%), $29.45 million in FY2022 (+6.2%) and $27.72 million in FY2021 (+47.6%).
- The Q2 2026 figure represents the highest quarterly Accumulated Expenses in data going back to Q4 2019.
- Year-over-year, Accumulated Expenses has increased for 23 consecutive quarters, with growth averaging 83.3% over the last eight quarters.
- The year-over-year growth in Accumulated Expenses has ranged between 6.2% (Q4 2022) and 153.7% (Q4 2023) over the last five years.
- Business Quant data shows RVMD's Accumulated Expenses at $192.45 million (Q1 2026), $209.34 million (Q4 2025) and $154.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 248.89 Mn |
| Mar 31, 2026 | 197.45 Mn |
| Dec 31, 2025 | 209.34 Mn |
| Sep 30, 2025 | 159.45 Mn |
| Jun 30, 2025 | 114.69 Mn |
| Mar 31, 2025 | 98.11 Mn |
| Dec 31, 2024 | 96.62 Mn |
| Sep 30, 2024 | 78.01 Mn |
| Jun 30, 2024 | 67.68 Mn |
| Mar 31, 2024 | 53.18 Mn |
| Dec 31, 2023 | 74.69 Mn |
| Sep 30, 2023 | 50.16 Mn |
| Jun 30, 2023 | 42.56 Mn |
| Mar 31, 2023 | 27.37 Mn |
| Dec 31, 2022 | 29.45 Mn |
| Sep 30, 2022 | 32.19 Mn |
| Jun 30, 2022 | 33.76 Mn |
| Mar 31, 2022 | 25.52 Mn |
| Dec 31, 2021 | 27.72 Mn |
| Sep 30, 2021 | 23.78 Mn |
API Access
Revolution Medicines Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();